Decreased antigen presentation by dendritic cells in patients with breast cancer

Clinical Cancer Research

Volumn 3, Issue 3, 1997, Pages 483-490

  Gabrilovich, Dmitry I ^a   Corak, Jadranco ^b   Ciernik, Ilja F ^c   Kavanaugh, Denise ^b   Carbone, David P ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TETANUS TOXOID;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLUENZA VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE;

BREAST NEOPLASMS; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-D ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; NEOPLASM STAGING; T-LYMPHOCYTES;

EID: 0030934973     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ioannides, C.,and Whiteside, T. T cell recognition of human tumors: implication for molecular immunotherapy of cancer. Clin. Immunol. Immunopathol.,66:91-106, 1993.
2. Cozzolino, F.,Torcia, M.,Carossino, A. M.,Giordani, R.,Selli, C.,Talini, G.,Reali, E.,Novelli, A.,Pistole, V.,and Ferrarini, M. Characterization of cells from invaded nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response. J. Exp. Med.,166: 303-318, 1987.
3. Belldegrun, A.,Kasid, A.,Uppenkamp, M.,Topalian, S. L.,and Rosenberg, S. A. Human tumor infiltrating lymphocytes: analysis of lymphokine mRNA expression and relevance to cancer immunotherapy. J. Immunol.,42:4520-4526, 1989.
4. Gabrilovich, D.,Ciemik, F.,and Carbone, D. P. Dendritic cells in anti-tumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell. Immunol.,170: 101-110, 1996.
5. Huang, A. Y. C.,Golumbek, P.,Ahmadzadeh, M.,Jaffee, E.,Pardoll, D.,and Levitsky, H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Washington DC), 264:961-965, 1994.
6. Rock, K. L.,Rothstein, L.,Gamble, S.,and Fleischacker, C. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol.,150: 438-446, 1993.
7. Zitvogel, L.,Mayordomo, J. I.,Tjandrawan, T.,DeLeo, A. B.,Clarke, M. R.,Lotze, M. T.,and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T hepler cell 1-associated cytokines. J. Exp. Med.,183:87-97, 1996.
8. Mayordomo, J. I.,Zorina, T.,Storkus, W. J.,Celluzzi, C.,Falo, L. D.,Melief, C. J.,Ildstad, T.,Kast, W. M.,DeLeo, A. B.,and Lotze, M. T. Bone-marrow derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med.,1: 1297-1302, 1995.
9. Hsu, F.,Benike, C.,Fagnoni, F.,Liles, T. M.,Czerwinsky, D.,Taidi, B.,Engleman, E. G.,and Levy, R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med.,2: 52-58, 1996.
10. Gabrilovich, D. I.,Nadaf, S.,Corak, J.,Berzofsky, J. A.,and Carbone, D. P. Dendritic cells in anti-tumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice are effective antigen carriers in the therapy of established tumors. Cell. Immunol.,170: 111-120, 1996.
11. Bhardwaj, N.,Bender, A.,Gonzalez, N.,Kim Bui, L.,Garrett, M. C.,and Steinman, R. M. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J. Clin. Invest.,94:797-807, 1994.
12. Romani, N.,Gruner, S.,Brang, D.,Kampgen, E.,Lenz, A.,Trockenbacher, B.,Konwalinka, G.,Fritsch, P.,Steinman, R. M.,and Schuler, G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med.,180:83-93, 1994.
13. Aoe, T.,Okamoto, Y.,and Saito, T. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med.,181:1881-1886, 1995.
14. Tan, K. C.,Hosoi, J.,Grabbe, S.,Asahina, A.,and Granstein, R. D. Epidermal cell presentation of tumor-associated antigens for induction of tolerance. J. Immunol.,153:760-767, 1994.
15. Zou, J-P.,Shimizu, J.,Ikegame, K.,Yamamoto, N.,Ono, S.,Fujiwara, H.,and Hamaoka, T. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen responsive CD4 + T cell activity. J. Immunol.,148:648-655, 1992.
16. Tas, M.,Simons, P.,Balm, F.,and Drexhage, H. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones. Cancer Immunol. Immunother.,36:108-114, 1993.
17. Erroi, A.,Sironi, M.,Chiaffarino, F.,Chen, Z. G.,Mengozzi, M.,and Mantovani, A. IL1 and IL6 released by tumor-associated macrophages from human ovarian carcinoma. Int. J. Cancer, 41:65-68, 1989.
18. Toriyama, K.,Wen, D. R.,Paul, E.,and Cochra, A. J. Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. J. Invest. Dermatol.,100:269S-273S, 1993.
19. Gabrilovich, D. I.,Chen, H. L.,Girgis, K. R.,Cunningham, H. T.,Meny, G. M.,Nadaf, S.,Kavanaugh, D.,and Carbone, D. P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med.,2: 1096-1103, 1996.
20. Liu, Y.,and Linsley, P. S. Costimulation of T cell growth. Curr. Opin. Immunol.,4:265-270, 1992.
21. Wade, W. F.,Davoust, J.,Salamero, J.,Andre, P.,Watts, T. H.,and Cambier, J. G. Structural compartmentalisation of MHG class II signalling function. Immunol. Today, 14:539-546, 1993.
22. Geppert, T. D.,and Lipsky, P. E. Activation of T lymphocytes by immobilized monoclonal antibodies to GD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants. J. Clin. Invest.,81:1497-1505, 1988.
23. Sallusto, F.,and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor. J. Exp. Med.,179: 1109-1118, 1994.
24. Bernhard, H.,Disis, M. L.,Heimfeld, S.,Hand, S.,Gralow, J. R.,and Cheever, M. A. Generation of immunostimulatory dendritic cells from human CD34 + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res.,55: 1099-1104, 1995.
25. Fisch, P.,Koller, G.,Garbe, A.,Herbst, B.,Wider, D.,Kohler, H.,Schaefer, H. E.,Mertelsmann, R.,Brugger, W.,and Kanz, L. Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patients. Eur. J. Immunol.,26:595-600, 1996.
26. Thomas, R. L.,Davis, L. S.,and Lipsky, P. E. Isolation and characterization of human peripheral blood dendritic cells. J. Immunol.,150: 821, 1993.
27. O'Doherty, U.,Peng, M.,Gezelter, S.,Swiggard, W. J.,Betjes, M.,Bahardawaj, N.,and Steinman, R. M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology, 82:487-493, 1994.
28. Pickl, W. F.,Majdic, O.,Kohl, P.,Stockl, J.,Riedl, E.,Scheinecker, C.,Bello-Fernandez, C.,and Knapp, W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol.,157:3850-3859, 1996.